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Inflammatory diseases of the
aorta
Part 1: Non-infectious aortitis
Study goal
Inﬂammatory changes to the aortic wall
can be caused by a multitude of dif-
ferent diseases. The broad spectrum of
pathogenic factors and nonspeciﬁc clin-
ical presentation often delay initial diag-
nosis; however, a precise determination
of the underlying pathology is essential
for successful management. The aim of
this article is to describe the pathogen-
esis, symptoms and diagnosis of aortitis
and equip the reader with the knowl-
edge required to perform adequate treat-
ment following anappropriate diagnostic
work-up.
Deﬁnition and classiﬁcation
The term aortitis encompasses inﬂam-
matory changes to the aortic wall from
varyingetiologies that are associatedwith
certain speciﬁc histopathological lesions.
The inﬂammatory response may be lim-
ited to the aortic wall or accompanied
by changes directly adjacent to the vessel
(e. g. retroperitoneal ﬁbrosis) or other
vessels (e. g. giant cell arteritis). A dis-
tinction is made between infectious and
non-infectious aortitis. Takayasu arteri-
tis and giant cell arteritis are the most
common causes of non-infectious aor-
titis [6, 7]; however, an association has
been shownbetweenother rheumatolog-
icaldiseasesand inﬂammatorychanges to
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the aortic wall, e. g. rheumatoid arthri-
tis, systemic lupus erythematosus, We-
gener’s granulomatosis and Behçet’s dis-
ease (. Tab. 1, [2]). It is essential to dif-
ferentiate between non-infectious causes
of aortitis and the much rarer infectious
causes, as treatment approaches diﬀer
greatly. Numerousbacteriahavebeende-
scribed as causative agents in infectious
inﬂammation, the most common being
Salmonella, Staphylococci and Pneumo-
cocci [4, 16]. More rarely, aortic wall in-
fections may be caused by mycobacteria
that inﬁltrate theaorticwall frominfected
lung tissue, lymphnodesorviamilia [22];
however, fungi andviruseshavealsobeen
described as causative agents in aortitis
[8, 20]. Part 2 of this continuing med-
ical education (CME) article provides a
detailed descriptionof infectious aortitis.
Non-infectious aortitis
Takayasu arteritis
Takayasu arteritis (synonyms: pulseless
disease, occlusive thromboaortopathy
andMartorell syndrome) is a chronic in-
ﬂammatory arteritis primarily aﬀecting
the large vessels, in particular the aorta
and its branches. Although case reports
date back as far as 1830 it was not until
1905 that the characteristic fundal lesions
were published by Takayasu, a profes-
sor of ophthalmology at the Kanazawa
University in Japan as ischemic neu-
ropathy of the optic nerve with annular
arteriovenous neo-anastomosis. The
disease is rare, with 5000 cases reported
throughout Japan between 1990 and
2000, while a US study put the incidence
at 2.6 cases per 1,000,000 inhabitants
per year. The incidence in European
countries is unknown. The majority of
cases are still seen in East Asia where
young females are almost exclusively
aﬀected [5]. A phase of asymptomatic
disease generally precedes clinically ap-
parent symptoms and ﬁndings. Disease
onset is generally seen in the second
or third decade of life, whereby the
interval between symptom onset and
diagnosis may be protracted (range 2–11
years [17]). Nonspeciﬁc symptoms in-
clude fever, nocturnal sweating, malaise,
weight loss, joint and muscle pain as
well as mild anemia. As vascular lesions
progress, stenosis and occlusion occur
with resultant ischemia to end organs [7].
Changes in the aortic region aﬀect the
abdominal section inparticular andneed
Tab. 1 Formsofunderlying rheumatic dis-
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Tab. 2 Diﬀerential diagnosis ofmid-aortic
syndrome





Tab. 3 American College of Rheumatol-
ogy criteria for the classiﬁcation criteria of
Takayasu arteritis which is highly probable
in thepresenceof threeormorecriteria (sen-
sitivity 91%and speciﬁcity 98% [33])
Age at disease onset < 40 years
Claudication of the extremities
Weak brachial artery pulse
Blood pressure diﬀerence > 10 mmHg be-
tween arms
Auscultable stenotic bruits over the subcla-
vian artery or abdominal aorta
Pathognomonic angiographic ﬁndings
to be diﬀerentiated from other causes
of atypical coarctation of the aorta (e.g.
mid-aortic syndrome) (. Tab. 2). The
aortic arch and its branches are aﬀected
almost equally. Characteristic features
include weakened or absent peripheral
pulse (pulseless disease), vascular bruits,
renal hypertension due to renal artery
stenosis, retinopathy, aortic valve insuf-
ﬁciency due to dilation of the valve ring
and subsequent dilated cardiomyopathy
and myocardial ischemia due to coro-
nary ostial stenosis. Syncope, epileptic
seizures and amaurosis fugax may occur
as a result of ischemic or hypertensive
cerebral damage. Carotidynia and ery-
thema nodosum are rare clinical ﬁndings
that may be linked to Takayasu arteritis.
In view of the frequently observed
manifestation of decreased perfusion of
internal organs or extremities, (duplex)
ultrasound plays an important role in the
basicdiagnosticwork-upandcanprovide
valuable early information about the cor-
rect diagnosis by diﬀerentiating between
stenoticmorphology and arteriosclerotic
lesions (. Fig. 1); nevertheless, modern
ultrasound methods are not yet able to
replace cross-sectional diagnostic imag-
ing. . Tab. 3 lists the speciﬁc diagnostic
criteria deﬁned by the American Col-
lege of Rheumatology (ACR). Computed
tomography (CT) angiography enables
Tab. 4 Diagnostic criteria for Takayasu arteritis according to Ishikawawhereby the presence of
twomajor criteria or onemajor and twominor criteria is highly suggestive for Takayasu arteritis
Major criteria Symptoms consistentwith Takayashu arteritis
Lesion in the mid-portion of the left subclavian artery
Lesion in the mid-portion of the right subclavian artery




Lesion in the pulmonary artery
Lesion in the mid-portion of the common carotid artery
Lesion in the region of the distal brachiocephalic trunk
Lesion in the region of the descending thoracic aorta
Lesion in the region of the abdominal arteries
Lesion in the region of the coronary arteries
visualization of the characteristic pat-
tern of involvement of the aorta and its
branches, while at the same time per-
mitting an assessment of the extent of
inﬂammatory changes to the vessel walls
(. Fig. 2). Digital subtraction angiogra-
phy(DSA)shouldonlybeused in the case
of speciﬁc questions or for interventional
purposes. Although vascular imaging
bymeans of contrast-enhancedmagnetic
resonance imaging (MRI) is possible, as-
sessing the vessel wall and neighboring
structures may be limited due to lower
spatial resolution depending on the ac-
quisition technique used ([28], . Figs. 3
and 4). Positron emission tomography-
computed tomography (PET-CT) plays
an increasingly important role in the as-
sessment of inﬂammatory activity ([14],
. Fig. 5).
While it is possible to classify patients
based on the pattern of aortic and aortic
branch involvement, this does not con-
tribute to assessing the prognosis. The
Ishikawa classiﬁcation [10] is more suit-
able for this as it takes complications al-
readypresent at the timeofdiagnosis into
consideration (. Tab. 4). There is a corre-
lation between classiﬁcation and patient
prognosis: the greater the number of ful-
ﬁlled minor criteria, the more severe and
complicated the disease course [11, 23].
Giant cell arteritis (synonyms:
Horton’s disease and temporal
arteritis)
First described in 1937 by Horton et al.
giant cell arteritis is the most common
form of non-infectious arteritis [cited in
10]. The aorta itself is aﬀected by inﬂam-
matory changes in only a subgroup of
patients [3]. Stenotic as well as aneurys-
mal lesions of the supra-aortic branches
are most commonly seen. This disease
predominantly aﬀects females aged over
50 years and the prevalence increases
with age. The incidence in Europe is
put at 15–25 per 100,000 inhabitants
per year, making it considerably higher
compared to Takayasu arteritis [5]. Pa-
tients generally seek medical advice for
headaches and impaired vision caused
by arteritic optic nerve neuropathy. A
history of jaw claudication indicating
involvement of the external carotid
artery and its branches is pathognomic
for this disease. Fever, muscle pain,
weight loss, cranial nerve deﬁcits and
double vision are rarer manifestations
[7, 12]. Temporal swelling along the
course of the temporal artery with ten-
derness on palpation is clinically striking
(. Fig. 6). Theerythrocyte sedimentation
rate (ESR) and C-reactive protein (CRP)
level are almost always both elevated.
Normocytic normochromic anemia and
thrombocytosis are also not uncommon.
Involvement of the subclavian artery can
cause arm claudication, pain at rest and
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ultimately lead to gangrene of the ﬁngers
and hands.
Early diagnosis is particularly impor-
tant in view of the prognosis of ophthal-
mological complications [19]. As with
Takayasu arteritis, the ACR has deﬁned
speciﬁc diagnostic criteria (. Tab. 5). A
temporal artery biopsy should be per-
formed (prior to initiating therapy) in ad-
ditiontotheclinicaland laboratory inves-
tigations mentioned previously. A mini-
mum biopsy length of at least 1.5–2 cm
is considered necessary due to segmental
involvement of the arterial wall. Doppler
and duplex ultrasound show characteris-
tic ﬁndings (hypoechoic borderor “halo”;
. Fig. 7, [1]); however, depending on the
initial ACR score (. Tab. 5) a number
of studies have shown sensitivity and
speciﬁcity to be signiﬁcantly lower com-
pared with temporal artery biopsy (69
and 82 vs. 93 and 91.2 %, respectively
[2, 13, 24]). Having said that, a high
ACR score and positive bilateral ultra-
sound ﬁndings generally make temporal
artery biopsies unnecessary. Cross-sec-
tional imaging methods, such as CT and
MRI are well-suited to assessing vessels
that cannot be visualized by ultrasound.
In the case of low ACR scores and equiv-
ocal ESR, CRP and biopsy ﬁndings, PET-




Aortic involvement has been described
in a number of systemic rheumatic dis-
eases; . Tab. 1 shows the most impor-
tant of these [2]. Suspicion of inﬂam-
matory aortic lesions should be aroused
if patients with signs of an underlying
rheumatic disease exhibit clinical indica-
tions of acute aortic valve insuﬃciency,
renal or mesenteric artery occlusion, de-
creased perfusion to the extremities or
aortic aneurysms in theabsenceof typical
risk factors for arteriosclerosis. In some
cases, however, the manifestation of typ-
ical clinical symptomsmay point the way
to the appropriate diagnosis (e. g. oral or
genital ulcerations in AAA are speciﬁc
for Behçet’s disease). Rational basic lab-
oratory diagnostics can be helpful here
from a number of perspectives: etiolog-
Abstract · Zusammenfassung
Gefässchirurgie 2016 · [Suppl 2]: 21:S80–S86 DOI 10.1007/s00772-016-0143-9
© The Author(s) 2016
I. Töpel · N. Zorger · M. Steinbauer
Inflammatory diseases of the aorta. Part 1: Non-infectious aortitis
Abstract
Aortitis is a term which encompasses
inﬂammatory changes to the aortic wall
from various pathogenic etiologies. Large
vessel vasculitis, such as Takayasu arteritis
and giant cell arteritis represent the most
common entities; however, there is also
an association with other rheumatological
diseases. Chronic idiopathic periaortitis
represents a distinct disease entity and
infectious aortitis is a rare but life-threatening
disease. Due to the diverse clinical pictures
vascular surgeons often face a signiﬁcant
challenge in terms of making an accurate
initial diagnosis. Treatment requires an
interdisciplinary approach. This article
describes the pathogenesis of the various
forms of aortitis as well as the diagnostic
methods and treatment approaches.
Keywords
Pathogenesis · Vasculitis · Arteritis · Aortic
infection · Rheumatic diseases
Entzündliche Erkrankungen der Aorta. Teil 1: Nichtinfektiöse
Aortitis
Zusammenfassung
Unter dem Begriﬀ der Aortitis werden ent-
zündliche Veränderungen der Aortenwand
verschiedener pathogenetischer Ursachen
zusammengefasst. Großgefäßvaskulitiden,
wie die Takayasu-Arteriitis und die Riesenzell-
arteriitis, stellen die häuﬁgsten Erkrankungen
dar, es ﬁndet sich aber auch eine Assoziation
mit anderen rheumatologischen Krankheiten.
Die chronische idiopathische Periaortitis stellt
eine eigene Entität dar. Eine infektiöse Aortitis
ist eine seltene aber lebensbedrohliche
Situation. Für den Gefäßmediziner ist es
auf Grund des vielgestaltigen klinischen
Bildes oft schwierig, eine exakte Erstdiagnose
zu stellen. Die Behandlung erfordert eine
interdisziplinäre Zusammenarbeit. Dieser
Beitrag soll Ursachen, diagnostischeMetho-
den und Therapieansätze der verschiedenen
Aortitiden darstellen.
Schlüsselwörter
Pathogenese · Vaskulitis · Arteriitis · Infektion
der Aorta · Rheumatische Erkrankungen
ical classiﬁcation of symptoms, type and
activity of the disease processes and an
evaluation of function of and damage to
aﬀected organ systems (. Tab. 6).
Treatment
Corticosteroids form the central pillar
of treatment in management of non-in-
fectious aortitis; for example, 40–60 mg
prednisone for 4 weeks followed by a
gradual dose reduction is the standard
treatment [18]. In addition to moni-
toring clinical symptoms the ESR is a
good follow-up parameter [18]. Some
authors recommend initial treatment
with 1,000 mg methyl prednisone daily
for 3 days in giant cell arteritis patients
with ocular symptoms (see Ness et al.
[20] for a detailed schedule). Eﬃcacy
varies from study to study and appears
to depend on the extent of inﬂammatory
lesions at the time of treatment initiation.
It is fair to assume that only one in every
two patients will fully respond to steroid
treatment; furthermore, steroid-induced
adverse eﬀects are seen in up to 65%
of patients, causing not inconsiderable
comorbidities. In such situations the
use of other steroid-sparing substances
can be considered. Three randomized
placebo-controlled studies on the use
of methotrexate in giant cell arteritis
yielded conﬂicting results, while one
meta-analysis found a certain advantage
conferred by 10–15 mg/week in terms
of reducing recurrence rates and steroid
dosage [15]. A randomized trial that
combined steroids with inﬂiximab also
revealed no advantages compared with
placebo [7]. A reduction in steroidmain-
tenance dose in patients with Takayasu
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Fig. 18 Takayasuarteritiswithbrachial artery involvementand typicalhalo
(arrow) on color duplex sonography (courtesy of Dr. G. Herzog)
Fig. 28Widening of the infrarenal aortic wall in a female patientwith
Takayasu arteritis
Fig. 39Magnetic reso-




in a female patientwith
Takayasu arteritis (arrows)
arteritis was possible with both aza-
thioprine (2 mg/kg body weight/day)
and methotrexate (20–25 mg/week [8,
31]). To date, cyclophosphamide has
been tested only in a small study on
adults with steroid-refractory Takayasu
arteritis. The administration of low-dose
acetylsalicylic acid (75–150 mg/day)
reduced the manifestation of cardiovas-
cular and cerebrovascular events in giant
cell arteritis patients [14, 19].
Interventional and conventional sur-
gicalmanagementof arterial occlusionor
aneurysms are guided by clinical symp-
toms and the basic principles of arte-
riosclerosis treatment. Although the re-
sults of reconstructive interventions are
good, the need for surgical revision is sig-
niﬁcantly increased in the long term [4].
Several authors recommend performing
revascularizationwhen inﬂammatoryac-
tivity is at its lowest [4, 16]. The restenosis
rate following interventional procedures,
such as angioplasty or angioplasty and
stents is higher compared with surgical
procedures [4, 12, 17, 23]. Data on the
use of drug-eluting stents or drug-eluting
balloons are lacking. Due to the rareness
of the disease there is a simple lack of evi-
dence tomake speciﬁc recommendations
on the selection of surgical or endovas-
cular procedures, the type of stents or
stent grafts to be used or resection in the
case of aneurysms.
Chronic idiopathic periaortitis
Since this disease was ﬁrst described ev-
idence has grown to suggest that in-
ﬂammatory abdominal aortic aneurysms
(IAAA) are not, as originally assumed,
a distinct entity but belong to a group
consisting of three symptom complexes
with the same etiology: (1) inﬂammatory
AAA, (2) idiopathic retroperitoneal ﬁ-
brosis (Ormond’s disease) and (3) a com-
bination of these two [6, 25].
Inflammatory aortic aneurysm
The term inﬂammatory aneurysm was
ﬁrst used by Walker in 1972 [cited
in 27] who described a group of aor-
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Fig. 48Magnetic resonanceangiography in thesamepatientas in.Fig. 3
showing inﬂammatory aneurysmsof the axillary arteries (arrows)
Fig. 58 Female patientwith Takayasu arteritis and positive positron emis-
sion tomography computed tomography showingmarked enhancement
around the aortic wall
Fig. 68Giant cell arteritis with the classical ﬁnding of painful segmental
thickening of the temporal artery (courtesy of Dr.G. Herzog)
Fig. 78Giant cell arteritis with involvement of the extracranial carotid
artery and typical halo (arrow) on color duplex sonography (courtesy of Dr.
G. Herzog)
tic aneurysms intraoperatively charac-
terized by a thickened wall, marked
perianeurysmal and retroperitoneal ﬁ-
brosis and adhesions to adjacent organs.
Inﬂammatory aneurysms account for
approximately 3–11% of all AAAs and
are predominantly seen in males. The
average age of onset is striking in that
it is 5–10 years lower that in patients
with non-inﬂammatory aneurysms [25].
Likewise, the proportion of smokers in
this group was signiﬁcantly higher at
77–100% [21]. There is evidence that a
familial tendency to aneurysm formation
is found 10 times more frequently in
patients with inﬂammatory aneurysm,
leading to the assumption of a genetic
predisposition [18].
Our understanding of the processes
that underlie aneurysm formation has
signiﬁcantly increased in recent years. It
is becoming apparent that a combina-
tion of genetically predisposing factors
and certain pathophysiological factors
cause aneurysm genesis through inﬂam-
matory degradation of the aortic wall.
Thus, according to current knowledge, it
is likely that inﬂammatory AAAdoes not
represent a separate disease entity but
is a particularly extreme variant of this
inﬂammatory process [21]. Although
the etiology of the clearly antigen-trig-
gered inﬂammatory response has not
been fully elucidated as yet, possibilities
include degradation products from lipids
deposited in the wall, elastin degrada-
tion products or infectious triggers (e.g.
Chlamydia pneumoniae, herpes simplex
virus and cytomegalovirus) [11, 22, 27,
28]. These lead in the further course
to the disintegration of the extracellular
matrix via the release and activation
of proteolytic enzymes from immune
cells, e. g. metallomatrix proteases.
Classically, bacterial pathogens are not
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Tab. 5 American College of Rheumatol-
ogy (ACR) criteria for giant cell arteritis and
three out of ﬁve criteria need to be fulﬁlled
for diagnosis
Age at initial manifestation > 50 years
New onset of headache
Temporal artery anomaly
Elevated erythrocyte sedimentation rate
Pathological temporal artery biopsy
detected on histopathological and mi-
crobiological analysis of the aneurysm
wall [3]. The onset of inﬂammatory
aneurysms is virtually always associ-
ated clinically with abdominal, back or
ﬂank pain (65–90%), which are seen
signiﬁcantly less frequently in non-in-
ﬂammatory aneurysms (8–18 % [29]).
Lack of appetite and weight loss are seen
in almost 50% of patients. In addition,
the ESR is generally strikingly elevated
(40–88 %). Although leukocytosis and
fever are seen in isolated cases they do
not represent typical elements of the
clinical picture [25]. The occurrence of
comorbidities, such as arteriosclerosis,
coronaryheart disease, hypertensionand
diabetes is the same as in patients with
non-inﬂammatory aneurysms; however,
ureteral involvement in periaortic in-
ﬂammation, which is seen in up to
50% of patients and not infrequently
causes chronic obstructive postrenal re-
nal dysfunction (18–21 %), is clinically
indicative.
Inﬂammatory AAA is diagnosed in-
traoperatively in themajority of cases, al-
thoughbothCT[9]andultrasound(halo)
show good diagnostic accuracy [28]. Ac-
cordingtoSterpetti etal. ureteral involve-
ment is best assessedusing a combination
of excretory pyelography and CT [25].
The inﬂammatory periaortic mass can
also be well visualized using contrast-en-
hancedMRI, whereby this method yields
other data necessary for perioperative
planning to a lesser extent [30]. The
inﬂammatory etiology of inﬂammatory
aortic aneurysms makes primarily drug-
based therapy with corticosteroids ap-
pear reasonable. Indeed, there are indi-
vidual reports on the complete resolu-
tion of clinical symptoms and all inﬂam-
matory changes to the aortic wall and
retroperitoneum under steroid therapy
Tab. 6 Rational laboratory diagnostics in the case of suspected aortitis
Basic laboratory tests Complete blood count (including diﬀerential blood count), uric
acid, creatine kinase, alkaline phosphatase, creatinine, gamma-
glutamyl transferase, aspartate aminotransferase, total protein,
protein electrophoresis, coagulation




Special laboratory tests Antineutrophil cytoplasmic antibodies (ANCA)
ANA diﬀerentiation
Double-stranded DNA antibodies (dsDNA-Ab)
Complement, HLA typing
[29]; however, a reduction in aneurysm
diameter has not been observed. If the
role of arteriosclerotic changes in the for-
mation of inﬂammatory aneurysm are
taken into consideration, the resulting
reduction in risk factors assumes crucial
importance. Abstention from tobacco
use in particular appears to have a pos-
itive eﬀect on disease course [28]. The
indications for surgical treatment are as-
sessed in much the same way as in non-
inﬂammatory aneurysms, whereby the
frequent onset of pain tends to prompt
early surgery.
The strategy of open aortic repair dif-
fers from non-inﬂammatory aneurysms
in that dissection should be kept to a
minimum. Attempts to detach inﬂam-
matory adhesions involving adjacent
organs, such as the duodenum, sig-
moid colon, vena cava or ureters from
the aneurysm can cause damage to
these organs and initially contributed to
signiﬁcantly higher morbidity and mor-
tality compared with non-inﬂammatory
aneurysms [1, 21]. As early as in 1985,
Crawford et al. recommended infradi-
aphragmatic cross-clamping to create
a proximal anastomosis [1]. The in-
ﬂamed wall can easily tear and should be
reinforced with polytetraﬂuoroethylene
(PTFE) pledgets. Thus, improvements in
surgical techniques have led to a gradual
reduction in the mortality rate, which
was virtually comparable with non-in-
ﬂammatoryAAA in the 1990s (6.8–11 %;
[26, 28, 32]). Anatomy permitting, there
appear to be no other obstacles to en-
dovascular treatment. Initial reports
show good results in terms of mortality
and morbidity, comparable with those
achieved with endovascular treatment of
arteriosclerotic aneurysms [13, 28]; how-
ever, it remains unclear why a regression
inﬁbrotic periaortitis is seen signiﬁcantly
less frequently following endovascular
treatment [26]. It is possible that the
endografts themselves are capable of
triggering an inﬂammatory reaction in
the aortic wall and directly adjacent
structures, as observed following treat-
ment of non-inﬂammatory aneurysms.
Thus, the indications for EndoVascular
Aneurysm Repair (EVAR), at least in
IAAA with ureteral involvement, should
be considered from a critical perspec-
tive [15]. A systematic review of the




This disease is characterized by the same
clinical, radiological and etiological fea-
tures as IAAA, diﬀering only in that
there is no aneurysm formation [6]. The
overlap and possible combinations in the
severity of individual symptoms are by
nature ﬂuid. Obstructive ureteral com-
plications, which canusually bemanaged
by placement of a splinting catheter, take
the foreground. Otherwise, treatment is
limited to the use of corticosteroids in
combination with immunosuppressants,
such as azathioprine, cyclophosphamide
and methotrexate, although it is diﬃcult
to predict individual responses to these
drugs [29].




of the aorta and its branches are associ-
ated with severe sequelae. Initially, di-
agnosis may be challenging due to the
nonspeciﬁc clinical presentation. Thus,
particularly in surgical disciplines it is of
crucial importance to “think of it in the
ﬁrst place.” Prompt intensive drug treat-
ment can reduce long-term morbidity in
many cases. Vascular surgery plays a
crucial role within the interdisciplinary
treatment team.
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